Keyphrases
Macrophages
100%
Macrophage Cells
100%
HIV Latency
100%
Latency-reversing Agents
100%
THP-1 Cells
100%
Bromodomain
100%
Monocyte-derived Macrophages
80%
Codon
60%
Enhanced Green Fluorescent Protein (eGFP)
60%
Kusabira Orange
60%
CD4+ T Cells
40%
Integration Site
40%
Phorbol 12-myristate 13-acetate
40%
Latently Infected Cells
40%
HIV Reactivation
40%
Viral Latency
40%
Genetic Manipulation
20%
Knockdown
20%
Virus
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
20%
HIV-1 Replication
20%
Histone Deacetylase Inhibitor (HDACi)
20%
Genetic Screening
20%
Latently Infected
20%
Lipopolysaccharide
20%
HIV Reservoir
20%
Replica Method
20%
THP1
20%
Latent HIV
20%
Bryostatin
20%
Single-cell Clone
20%
Elongation Factor
20%
Pharmacological Effects
20%
Primary Monocytes
20%
Dual-labeling
20%
Deactivation
20%
Ionomycin
20%
Bromodomain Inhibitors
20%
Macrophage-like
20%
Bromodomain-containing Protein 4 (BRD4)
20%
I-BET151
20%
LTR Promoter
20%
DYRK1A Inhibitor
20%
Latency Model
20%
Harmine
20%
Immunology and Microbiology
Macrophage
100%
Human Immunodeficiency Virus
100%
Codon
25%
T-Helper Cell
16%
Promoter Region
16%
Human Immunodeficiency Virus 1
8%
Bryostatin 1
8%
Genetic Screening
8%
Genetic Manipulation
8%
Cell Clone
8%
Elongation Factor
8%
Virus
8%
Histone
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Sweet Orange
27%
12-O-Tetradecanoylphorbol-13-Acetate
18%
Bryostatin 1
9%
Histone Deacetylase Inhibitor
9%
Lipopolysaccharide
9%
Bromodomain Inhibitor
9%
Alfacalcidol
9%
Ionomycin
9%
Elongation Factor
9%
Harmine
9%